FR3080278B1 - PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE - Google Patents

PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE Download PDF

Info

Publication number
FR3080278B1
FR3080278B1 FR1853165A FR1853165A FR3080278B1 FR 3080278 B1 FR3080278 B1 FR 3080278B1 FR 1853165 A FR1853165 A FR 1853165A FR 1853165 A FR1853165 A FR 1853165A FR 3080278 B1 FR3080278 B1 FR 3080278B1
Authority
FR
France
Prior art keywords
cannabidiol
active
manufacturing
active principle
spheroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1853165A
Other languages
French (fr)
Other versions
FR3080278A1 (en
Inventor
Michel Iderne
Olivier Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ghs Patents Ltd
Original Assignee
Ghs Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghs Patents Ltd filed Critical Ghs Patents Ltd
Priority to FR1853165A priority Critical patent/FR3080278B1/en
Priority to PCT/IB2019/052937 priority patent/WO2019198001A1/en
Publication of FR3080278A1 publication Critical patent/FR3080278A1/en
Application granted granted Critical
Publication of FR3080278B1 publication Critical patent/FR3080278B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Abstract

Procédé de fabrication d'un sphéroïde comprenant du cannabidiol dans lequel : a) On mélange un principe actif isolé, une solution active d'origine végétale contenant ledit principe actif ou un précurseur de celui-ci, avec une substance absorbante et adsorbante présentant des propriétés plastiques, b) on extrude ledit mélange jusqu'à obtention d'un produit extrudé, c) on sphéronise ledit produit extrudé jusqu'à obtention d'un sphéroïde, caractérisé en ce que ledit principe actif isolé consiste en du cannabidiol et en ce que ladite solution active d'origine végétale consiste en un extrait actif, issu d'un végétal du genre Cannabis sativa L, contenant du cannabidiol et/ou un précurseur de cannabidiol.Process for manufacturing a spheroid comprising cannabidiol in which: a) an isolated active principle, an active solution of plant origin containing said active principle or a precursor thereof, is mixed with an absorbent and adsorbent substance exhibiting properties plastics, b) said mixture is extruded until an extruded product is obtained, c) said extruded product is spheronized until a spheroid is obtained, characterized in that said isolated active principle consists of cannabidiol and in that said active solution of plant origin consists of an active extract, derived from a plant of the genus Cannabis sativa L, containing cannabidiol and / or a cannabidiol precursor.

FR1853165A 2018-04-11 2018-04-11 PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE Active FR3080278B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1853165A FR3080278B1 (en) 2018-04-11 2018-04-11 PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE
PCT/IB2019/052937 WO2019198001A1 (en) 2018-04-11 2019-04-10 Method for producing a spheroid comprising cannabidiol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1853165 2018-04-11
FR1853165A FR3080278B1 (en) 2018-04-11 2018-04-11 PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE

Publications (2)

Publication Number Publication Date
FR3080278A1 FR3080278A1 (en) 2019-10-25
FR3080278B1 true FR3080278B1 (en) 2021-04-30

Family

ID=66476677

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1853165A Active FR3080278B1 (en) 2018-04-11 2018-04-11 PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE

Country Status (2)

Country Link
FR (1) FR3080278B1 (en)
WO (1) WO2019198001A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
FR2794346B1 (en) * 1999-06-02 2004-08-06 Ile D Inventeurs Apis Spheromo FORMULATION AND METHOD FOR THE PRODUCTION OF SPHEROIDS FROM A FERMENTED BEVERAGE OR A FERMENTED JUICE FOR EXAMPLE OF WINE
ES2516693T3 (en) * 2006-03-16 2014-10-31 Euro-Celtique S.A. Pharmaceutical spheroids
WO2008021394A2 (en) * 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use

Also Published As

Publication number Publication date
FR3080278A1 (en) 2019-10-25
WO2019198001A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
Ma et al. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model
BR0306717A (en) Pharmaceutical dosage forms and methods for producing same
CL2019002247A1 (en) Polyhalite granulation process.
BRPI0519860A2 (en) extruder system and process for fluid extrusion, injector
BR112017017574A2 (en) process for the production of a formaldehyde stabilized urea product.
Park et al. Oligonol promotes anti-aging pathways via modulation of SIRT1-AMPK-Autophagy Pathway
FR3080278B1 (en) PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE
CH708024B8 (en) Method for producing a pipette.
FR3052978B1 (en) PROCESS FOR OBTAINING A DIGLYCOSIDE-ENRICHED ARMERIA MARITIMA EXTRACT AND ITS USE IN COSMETICS
FR3048982B1 (en) METHOD OF MANUFACTURING PAPER IMPREGNATED BY A SUPERCRITICAL PRESSURE FLUID - IMPREGNATED PAPER, ESPECIALLY COLORED
FR3027602B1 (en) PROCESS FOR THE SYNTHESIS OF A HYDROXYARYL GROUP-CARRYING POLYMER, PRODUCT THEREOF AND COMPOSITION CONTAINING THE SAME
FR3069413B1 (en) HYDROSOLUBLE PROPOLIS EXTRACT, PROCESS FOR OBTAINING AND USE FOR PREVENTING AND / OR COMBATING PLANT DISEASES
BRPI0405436A (en) Process for the production of unsaturated carboxylic acids or unsaturated nitriles
WANG et al. Prospects of obtaining carrageenase from Polar microorganisms
FR3027904B1 (en) PROCESS FOR THE SYNTHESIS OF A HYDROXYARYL GROUP-CARRYING POLYMER, PRODUCT THEREOF AND COMPOSITION CONTAINING THE SAME
BR102014017043B8 (en) DOMESTIC SEWAGE TREATMENT SYSTEM BY BIODIGESTION
XIONG Promotion of Ziyuglycoside I on white blood cells by autophagy pathway
Jin et al. Anti-allergic activity of crystallinity controlled N-acetyl glucosamine
Massimino discovery of terpenoid metabolism in In silico Cannabis sativa
EP3485952A3 (en) Ecological method for improving the availability of active substances from plant materials, use in animal feed and food composition
FR3064194B1 (en) PROCESS FOR PREPARING A TRAPPING MATERIAL OF COMPOUNDS AND MATERIAL THUS OBTAINED
Ha Microfluidic method as a promising technique for synthesizing antimicrobial compounds
CH292092A (en) Process for the production of stable mixtures containing polymers suitable for further processing.
Laguta et al. Antioxidant/reducing properties of the extracts from the genus Vítex plant leaves
CN203000955U (en) Vacuum blood collection tube capable of protecting activity of hirudin

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200228

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6